Peters, S., Lee, Y., Erman, M., Liu, S. V., Solomon, B. J., Kato, T., Lu, S., Popat, S., Gunaydin, U. M., Bartz, R., Patel, V., Tsai, K., Li, L., Dimkpa, U. C., Gann, C., OBrate, A., Celik, I., Türeci, Ã., Åžahin, U., Cho, B. C. (2026). Phase 2 data from ROSETTA Lung-02, a global randomized phase 2/3 trial of pumitamig (PD-L1 × VEGF-A bsAb) + chemotherapy in 1L NSCLC.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8513